rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2010-11-4
|
pubmed:abstractText |
Intermittent preventive treatment (IPT) of malaria involves administration of curative doses of antimalarials at specified time points to vulnerable populations in endemic areas, regardless whether a subject is known to be infected. The effect of this new intervention on the development and maintenance of protective immunity needs further understanding. We have investigated how seasonal IPT affects the genetic diversity of Plasmodium falciparum infections and the risk of subsequent clinical malaria.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amodiaquine,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Antimalarials,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos,
http://linkedlifedata.com/resource/pubmed/chemical/Protozoan Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimethamine,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfadoxine,
http://linkedlifedata.com/resource/pubmed/chemical/merozoite surface protein 2...,
http://linkedlifedata.com/resource/pubmed/chemical/sulfadoxine-pyrimethamine
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1932-6203
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e13649
|
pubmed:meshHeading |
pubmed-meshheading:21048970-Amodiaquine,
pubmed-meshheading:21048970-Antigens, Protozoan,
pubmed-meshheading:21048970-Antimalarials,
pubmed-meshheading:21048970-Child, Preschool,
pubmed-meshheading:21048970-Cross-Sectional Studies,
pubmed-meshheading:21048970-Drug Combinations,
pubmed-meshheading:21048970-Ghana,
pubmed-meshheading:21048970-Humans,
pubmed-meshheading:21048970-Infant,
pubmed-meshheading:21048970-Malaria, Falciparum,
pubmed-meshheading:21048970-Placebos,
pubmed-meshheading:21048970-Protozoan Proteins,
pubmed-meshheading:21048970-Pyrimethamine,
pubmed-meshheading:21048970-Risk Factors,
pubmed-meshheading:21048970-Sulfadoxine
|
pubmed:year |
2010
|
pubmed:articleTitle |
Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum infections on clinical malaria risk.
|
pubmed:affiliation |
Infectious Diseases Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|